- Home
- NYC vs NXGL Comparison
NYC vs NXGL Comparison
Compare NYC & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYC
- NXGL
- Stock Information
- Founded
- NYC 2013
- NXGL 1997
- Country
- NYC United States
- NXGL United States
- Employees
- NYC N/A
- NXGL N/A
- Industry
- NYC Real Estate
- NXGL Medical/Dental Instruments
- Sector
- NYC Finance
- NXGL Health Care
- Exchange
- NYC Nasdaq
- NXGL Nasdaq
- Market Cap
- NYC 23.8M
- NXGL 22.7M
- IPO Year
- NYC N/A
- NXGL 2021
- Fundamental
- Price
- NYC $8.51
- NXGL $4.64
- Analyst Decision
- NYC
- NXGL
- Analyst Count
- NYC 0
- NXGL 0
- Target Price
- NYC N/A
- NXGL N/A
- AVG Volume (30 Days)
- NYC 3.3K
- NXGL 157.4K
- Earning Date
- NYC 11-12-2024
- NXGL 11-13-2024
- Dividend Yield
- NYC N/A
- NXGL N/A
- EPS Growth
- NYC N/A
- NXGL N/A
- EPS
- NYC N/A
- NXGL N/A
- Revenue
- NYC $62,060,000.00
- NXGL $6,729,000.00
- Revenue This Year
- NYC N/A
- NXGL $120.47
- Revenue Next Year
- NYC $3.18
- NXGL $38.19
- P/E Ratio
- NYC N/A
- NXGL N/A
- Revenue Growth
- NYC N/A
- NXGL 90.57
- 52 Week Low
- NYC $5.46
- NXGL $1.84
- 52 Week High
- NYC $10.91
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- NYC 47.19
- NXGL 69.32
- Support Level
- NYC $7.96
- NXGL $4.11
- Resistance Level
- NYC $9.15
- NXGL $5.10
- Average True Range (ATR)
- NYC 0.50
- NXGL 0.36
- MACD
- NYC 0.05
- NXGL 0.12
- Stochastic Oscillator
- NYC 49.21
- NXGL 74.48
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.